Recce Pharmaceuticals Ltd (ASX:RCE)
Australia · Delayed Price · Currency is AUD 0.3300
0.00 (0.00%)
Nov 9, 2026, 10:21 AM AEDT
Recce Pharmaceuticals Market Cap
Recce Pharmaceuticals has a market cap or net worth of 100.9 million as of November 6, 2026. It is the 27,496th most valuable company in the world and the 608th biggest in Australia. Its market cap has decreased by 13.84% in one year.
Market Cap
100.90M
Enterprise Value
108.41M
Revenue
9.47M
Global Rank
Country Rank
#608 Australia
PE Ratio
n/a
ChartMarket Cap Chart
Since January 15, 2016, Recce Pharmaceuticals's market cap has increased from 20.55M to 100.90M, an increase of 391.08%. That is a compound annual growth rate of 15.84%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 8, 2026 | 100.90M | -46.32% |
| Dec 31, 2025 | 187.97M | 67.15% |
| Dec 31, 2024 | 112.46M | 3.19% |
| Dec 29, 2023 | 108.98M | -7.28% |
| Dec 30, 2022 | 117.53M | -34.34% |
| Dec 31, 2021 | 179.00M | -2.33% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Actinogen Medical | 157.76M |
| Orthocell | 156.63M |
| Paradigm Biopharmaceuticals | 153.48M |
| Dimerix | 123.08M |
| Nyrada | 122.56M |
| Island Pharmaceuticals | 96.23M |
| LTR Pharma | 76.56M |
| Prescient Therapeutics | 61.77M |